Search

everythinglearnresearchcommunity

for

Search:↓

Most women with Polycystic Ovarian Disease have trouble getting pregnant due to hormonal imbalances, but lifestyle changes and certain drugs can help.

The document covers various male health issues, their causes, treatments, and related conditions.

PCOS is a common hormonal disorder in women that can be managed with lifestyle changes and various medications.

Women with PCOS have higher levels of AMH in their blood and follicles, and this can help predict their risk of overreaction to fertility treatments.

Manage PCOS in primary care with weight loss, psychological support, medication, and monitoring for health risks.

Understanding drug interactions, side effects, and patient-specific factors is crucial for effective dermatological care.

Some common medications can harm male fertility, but many effects can be reversed.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

High doses of cyproterone acetate increase the risk of brain tumors in women, but the risk decreases after stopping the medication.

The document reviews key historical figures and discoveries in dermatology.

Rare ULBP3 gene changes may raise the risk of Alopecia areata, a certain FAS gene deletion could cause a dysfunctional protein in an immune disorder, and having one copy of a specific genetic deletion is okay, but two copies cause sickle cell disease.

PCOS affects women's health by increasing the risk of diabetes, heart disease, and reproductive issues.

Buschke-Ollendorff syndrome is a rare genetic disorder causing skin and bone changes, with some cases also showing ADHD or developmental delays.

The modified Ferriman-Gallwey method is a useful tool for diagnosing hirsutism.

Cyproterone acetate is effective for treating hirsutism and acne but less so for hair loss, with side effects similar to birth control pills.

Different types of fibroblasts play various roles in both healthy and diseased tissues, and understanding them better could improve treatments for fibrotic diseases.

Telogen effluvium is a hair loss condition caused by various factors and requires a thorough examination to diagnose and differentiate from other hair loss types.

Valproic acid helped hair growth in alopecia patient; more research needed.

Some chemicals and drugs can cause hair loss, which usually grows back after stopping the treatment.

Higher lead and cadmium, and lower zinc and iron levels in the blood might be linked to chronic hair loss in women.

The most common cause of hair loss in children is tinea capitis, followed by alopecia areata and telogen effluvium.

The conclusion is that hirsutism should be diagnosed and treated because it affects quality of life and may signal other health problems.

High levels of prolactin in the blood can be linked to widespread hair loss.

Idiopathic hirsutism causes excessive hair growth in women, can be treated with medication and hair removal, but cannot be fully reversed.

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

Low iron levels may be linked to hair loss in women with chronic telogen effluvium.

Baicapil was effective in reducing hair loss and increasing hair growth in women with telogen effluvium.

Effective hirsutism management requires identifying the cause, combining new and traditional treatments, and setting realistic expectations for patients.

Blocking IL-1 could help treat some hair loss conditions; alopecia affects liver detox systems; spironolactone is better than finasteride for female hair growth; focusing on the catagen hair phase could lead to new alopecia treatments.

Stress in mice delays hair growth and treatments blocking substance P can partly reverse this effect.